Adrian Bot, M.D., Ph.D.

Chief Scientific Officer and EVP, R&D at Capstan Therapeutics

Adrian Bot, M.D., Ph.D. is the founding Chief Scientific Officer and Executive Vice President of Research and Development at Capstan Therapeutics, a company developing next generation precision medicines. Previously, he held leadership roles at Kite Pharma and Kite, a Gilead Company, including Chief Scientific Officer and Vice President of Translational Medicine, respectively. Dr. Bot has 24 years of experience in biopharmaceutical industry with focus on discovery and development of targeted therapies in general, and immunotherapies in particular. He obtained his M.D. in Romania in 1993 and his Ph.D. in Biomedical Sciences at Mount Sinai School of Medicine in New York in 1998.